Previous 10 | Next 10 |
2024-04-04 11:12:55 ET More on Health Care Select Sector SPDR: XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Eli...
2024-03-27 16:05:32 ET Summary Inari Medical, Inc.'s share price has dropped due to an investigation on doctor payment practices, creating a buying opportunity for risk-willing investors. Inari creates mechanical thrombectomy products for VTE and PE, with high potential operating ...
2024-03-27 15:04:20 ET More on J&J, ShockWave Medical, etc. Johnson & Johnson (JNJ) Barclays 26th Annual Global Healthcare Conference (Transcript) Johnson & Johnson (JNJ) Leerink Partners Global Biopharma Conference (Transcript) Johnson & Johnson (JNJ...
2024-02-23 12:46:54 ET More on Penumbra Penumbra, Inc. (PEN) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Penumbra Historical earnings data for Penumbra Financial information for Penumbra Read the full article on Seeking A...
2024-02-22 20:55:04 ET Penumbra, Inc. (PEN) Q4 2023 Earnings Conference Call February 22, 2024 4:30 PM ET Company Participants Jee Hamlyn-Harris – Investor Relations Adam Elsesser – Chairman and Chief Executive Officer Maggie Yuen – Chief Fin...
2024-02-22 16:38:06 ET More on Penumbra Seeking Alpha’s Quant Rating on Penumbra Historical earnings data for Penumbra Financial information for Penumbra Read the full article on Seeking Alpha For further details see: Penumbra GAAP EPS of $...
2024-02-22 16:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Penumbra, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results PR Newswire ALAMEDA, Calif. , Feb. 22, 2024 /PRNewswire/ -- Penumbra, Inc. ( NYSE: PEN ) , a global healthcare company focused on innovative therapies, today reported financia...
2024-02-21 17:20:44 ET More on Penumbra Seeking Alpha’s Quant Rating on Penumbra Historical earnings data for Penumbra Financial information for Penumbra Read the full article on Seeking Alpha For further details see: Penumbra Q4 2023 Earni...
Penumbra, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 22, 2024 PR Newswire ALAMEDA, Calif. , Feb. 1, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to disc...
News, Short Squeeze, Breakout and More Instantly...
Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024 PR Newswire ALAMEDA, Calif. , July 2, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial resu...
A look at the top 10 most actives in the United States SMX (Security Matters) Public Limited Company (SMX) rose 43.0% to $0.1702 on volume of 99,421,591 shares NVIDIA Corporation (NVDA) rose 3.5% to $140.3486 on volume of 71,277,917 shares MGO Global Inc. (MGOL) rose 222.9% to $1.48 on vo...
A look at the top 10 most actives in the United States Reliance Global Group Inc. (RELI) rose 76.2% to $0.3911 on volume of 383,719,808 shares NLS Pharmaceutics Ltd. (NLSP) rose 82.1% to $0.2701 on volume of 302,290,803 shares NVIDIA Corporation (NVDA) rose 3.5% to $135.58 on volume of 28...